COMMUNIQUÉS West-GlobeNewswire

Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®

01/07/2024 - 15:15

Asset acquisition expands Merit’s endoscopy portfolio with a minimally invasive solution for patients suffering from chronic gastroesophageal reflux disease (GERD). Asset acquisition projected to add approximately $30 [...]

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024

01/07/2024 - 15:00

ZTlido ® net sales for the month of June 2024 grew in the range of 70% to 104%, compared to the same period last year. ZTlido ® net sales for the quarter ended June 2024 grew in the range of 28% to 42%, compared to the [...]

TRACON Pharmaceuticals Announces Termination of ENVASARC Trial and Will Explore Strategic Alternatives Leveraging its In-House Product Development Platform

01/07/2024 - 15:00

The objective response rate by blinded independent central review in the fully enrolled ENVASARC pivotal trial in the 82 evaluable patients is 5% (four responders) and did not meet the primary endpoint of 11% Company [...]

Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium

01/07/2024 - 15:00

SOLANA BEACH, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]

Ricky Williams Applauds NCAA’s Decision to Remove Cannabinoids from Banned Substances List, Emphasizes Need for Education on Cannabis

01/07/2024 - 15:00

LOS ANGELES, July 01, 2024 (GLOBE NEWSWIRE) -- Ricky Williams, former Heisman Trophy winner, renowned cannabis advocate, and founder of the cannabis brand Highsman, has expressed his strong support for the NCAA's recent [...]

Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes

01/07/2024 - 15:00

SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today [...]

GRI Bio to Present at the 8th Annual IPF Summit

01/07/2024 - 14:45

LA JOLLA, CA, July 01, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the [...]

Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL)

01/07/2024 - 14:30

Patient Screening is Underway at Rocky Mountain Cancer Centers, Part of the US Oncology Network and Sarah Cannon Research Institute; Astera Cancer Care, Part of the OneOncology Network; and Norton Cancer Institute [...]

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

01/07/2024 - 14:30

Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness LOS ANGELES, July 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics [...]

Foxo Technologies, Inc., Regains Compliance with SEC Reporting Requirements

01/07/2024 - 14:30

MINNEAPOLIS, July 01, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced it has filed its Form 10-Q for the quarter ended March, 31, 2024 and in doing so has regained [...]

Inside information: Orion upgrades full-year outlook for 2024

01/07/2024 - 14:15

ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 1 JULY 2024 at 15:15 EEST Inside information: Orion upgrades full-year outlook for 2024 Orion Corporation upgrades the full-year outlook for 2024 both for [...]

Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer

01/07/2024 - 14:15

ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 1 JULY 2024 at 15:15 EEST Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an [...]

Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy

01/07/2024 - 14:05

$8M grant supports ongoing Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia SOUTH SAN FRANCISCO, Calif., July 01, 2024 (GLOBE [...]

Kraig Biocraft Laboratories Expands Facilities to Support Spider Silk Production Growth

01/07/2024 - 14:05

ANN ARBOR, Mich., July 01, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that it has achieved full capacity at its current production location [...]

NeuroStar® Launches Better Me Provider Program Nationwide

01/07/2024 - 14:02

The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry MALVERN, Pa., July 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a [...]

G1 Therapeutics Added to the Russell 2000® and 3000® Indexes

01/07/2024 - 14:00

RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced that the Company has been added to the broad-market Russell [...]

Spectral AI Joins Russell Microcap® Index

01/07/2024 - 14:00

DALLAS, July 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327

01/07/2024 - 14:00

Results demonstrate efficacy on bacterial growth in participants injected with RECCE ® 327 (R327) at the highest tested dose of 4,000mg No serious adverse events and clinically significant changes observed, reinforcing [...]

Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations

01/07/2024 - 14:00

The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results indicate that the target pharmacokinetic [...]